# New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

> **NCT00074828** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 511 (actual)

## Conditions studied

- Total Knee Replacement
- Total Hip Replacement

## Interventions

- **DRUG:** LY517717
- **DRUG:** enoxaparin

## Key facts

- **NCT ID:** NCT00074828
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2008-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00074828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00074828, "New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00074828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*